DRNA
Dicerna Pharmaceuticals Inc
Price:  
38.22 
USD
Volume:  
5,675,031.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DRNA Fair Value

-119.46 %
Upside

As of 2024-03-04, the Fair Value of Dicerna Pharmaceuticals Inc (DRNA) is -7.44 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 38.22 USD, the upside of Dicerna Pharmaceuticals Inc is -119.46%.

Note: valuation result may not be accurate due to the company's negative EPS.

38.22 USD
Stock Price
-7.44 USD
Fair Price
FAIR VALUE CALCULATION

DRNA Fair Value

Peter Lynch's formula is:

DRNA Fair Value
= Earnings Growth Rate x TTM EPS
DRNA Fair Value
= 5.00 x -1.49
DRNA Fair Value
= -7.44

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
- - - - - 5Y Avg
Net income - - - - - -
YoY growth - - - - - -%

DRNA Fair Value - Key Data

Market Cap (mil) 2,895.55
P/E
Forward P/E
EPS -1.49
Avg earnings growth rate -%
TTM earnings -124.45